Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Inflamm Bowel Dis. 2011 Feb 10;17(5):1229–1245. doi: 10.1002/ibd.21557

TABLE 3.

Updated STAIR Recommendations for Preclinical Stroke Studies*

Randomization The method by which animals are allocated to the different groups should be described.
Sample Size Calculation The method for how sample size of each group is calculated should be described.
Inclusion/Exclusion Criteria The criteria for including as well as excluding animals from data analyses should be described.
 All randomized animals should be accounted for in data presentation unless clearly delineated.
Allocation Concealment The method for allocation concealment should be described. Allocation is concealed if the
 investigator responsible for the treatment and follow up care of animals is unaware of the
 treatment identity.
Blinded Assessment of Outcome The assessment outcome is blinded if the investigator responsible for quantifying outcomes
 (e.g. histopathology) is unaware of animal treatment group.
Reporting Conilicts of Interest
 and Study Funding
Presence or absence of any perceived conflict of interest should be reported.
*

Table modified from Fisher et al. (24).